Providers and state legislators continue to clash with BlueCross BlueShield of Tennessee over the insurer’s plan to lower costs for some self-funded employer groups by targeting provider-administered specialty drugs — the most expensive of all pharmaceuticals. Traditionally, providers buy these …

Some providers who infuse specialty drugs say a new policy from Tennessee’s largest health insurance company could cause them to end the service, threatening their practice and forcing patients to find a new place to receive their life-changing drug infusions. …